David DeLucia insider trades
Open-market stock purchases and sales by David DeLucia, Chief Financial Officer at Kyntra BIO, Inc, from SEC Form 4 filings since Jan 9, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 6, 2026 | KYNB Kyntra BIO, Inc | Sold (not open market) | $188 |
| Jun 6, 2026 | KYNB Kyntra BIO, Inc | Sold (not open market) | $349 |
| Mar 6, 2026 | KYNB Kyntra BIO, Inc | Sold (not open market) | $410 |
| Feb 3, 2026 | KYNB Kyntra BIO, Inc | Bought (not open market) | — |
| Dec 6, 2025 | FGEN Fibrogen Inc | Sold (not open market) | $438 |